Drug maker Eli Lilly is making a bet on rising global demand for animal drugs and vaccines with a deal to acquire Novartis AG's animal-health business for $5.4 billion.
via WSJ.com: US Business http://ift.tt/1tybU2Q
via WSJ.com: US Business http://ift.tt/1tybU2Q
Nessun commento:
Posta un commento